At Novo Nordisk, our R&D pipeline
reflects our long-standing commitment to driving change to
defeat diabetes and other serious chronic conditions. Our scientists
are currently working on novel and innovative treatments to address
the unmet needs of people living with diabetes, obesity, haemophilia,
growth disorders and non-alcoholic steatohepatitis (NASH).
Browse our entire R&D pipeline by study phase, or select specific therapy areas below.
Click on a candidate to access up-to-date trial information.
We are always looking for scientific talent to join us. If you are
interested in joining our research and development teams, explore your
opportunities at our careers page.
We publish our scientists’ new findings as often as possible. Visit our library to explore some of their recent work.